234 related articles for article (PubMed ID: 12115)
1. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
2. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
3. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
4. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
Frick MH; Pörsti P
Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
[TBL] [Abstract][Full Text] [Related]
5. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
6. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
Dent R; Kellaway GS
N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
[TBL] [Abstract][Full Text] [Related]
7. Double-blind trial of labetalol.
Kane J; Gregg I; Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
[TBL] [Abstract][Full Text] [Related]
8. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
Johnson BF; LaBrooy J; Munro-Faure AD
Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
[TBL] [Abstract][Full Text] [Related]
9. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
Cybulska I; Sznajderman M; Brym E; Czerniewska E
Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
[No Abstract] [Full Text] [Related]
10. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
[No Abstract] [Full Text] [Related]
11. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension with labetalol.
Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of arterial hypertension with labetalol. A polycentric study].
G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
[TBL] [Abstract][Full Text] [Related]
14. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
Pearson RM; Havard CW
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
[TBL] [Abstract][Full Text] [Related]
15. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
16. Experience with labetalol in hypertension.
Bolli P; Waal-Manning J; Wood AJ; Simpson FO
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
18. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
Johnson BF; LaBrooy J; Munro-Faure AD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
[TBL] [Abstract][Full Text] [Related]
19. Labetalol as a hypotensive agent in otological operations.
Pakkanen A; Kanto J
Ann Chir Gynaecol; 1979; 68(2):82-3. PubMed ID: 41475
[TBL] [Abstract][Full Text] [Related]
20. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
Vas A; Gachályi B; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
